Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01944215 · ClinicalTrials.gov registry record · Phase 1

Evaluation of the Effect of Fasting and Exercise on Uptake of Tc-99m Sestamibi in Breast Tissue

A Phase 1 study, sponsored by Mayo Clinic.

Completed
Registry status
Phase 1
Development phase
154
Enrollment target

NCT01944215: Completed Phase 1 study, sponsored by Mayo Clinic.

NCT01944215 is a Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 154 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (157% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01944215, a Phase 1 study, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
Phase 1
Development phase
154 participants
Enrollment target

Study Summary

The primary objective of this study is to determine if exercise, fasting, or eating prior to the molecular breast imaging study will have an effect on the uptake of the tracer in the breast tissue.

Primary Outcome

Quantitative measurements of Tc-99m sestamibi uptake will be performed to measure the relative change in uptake between the two MBI scans.

Interventions

  • OTHER Exercise
  • DRUG Caffeine Tablet
  • DIETARY_SUPPLEMENT Meal
  • RADIATION Sestamibi
  • OTHER External Heating

Trial Details

FieldValue
Enrollment Target 154 participants
Start Date 2013-09
Est. Completion 2015-04
Phase Phase 1
Mayo Clinic

2,844 total trials

What the finished NCT01944215 record still lists

NCT01944215 is an interventional study that assigns participants to a tested intervention. The registered 154 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (157% higher).

The record links to 0 conditions, and to 5 interventions - of which Exercise is the first listed.

NCT01944215 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01944215 about?

NCT01944215 is a clinical study titled "Evaluation of the Effect of Fasting and Exercise on Uptake of Tc-99m Sestamibi in Breast Tissue". The primary objective of this study is to determine if exercise, fasting, or eating prior to the molecular breast imaging study will have an effect on the uptake of the tracer in the breast tissue.

What is the current status of trial NCT01944215?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 154 participants. The study started on 2013-09. Estimated completion is 2015-04.

What interventions are being tested in trial NCT01944215?

The interventions under investigation include: Exercise (OTHER), Caffeine Tablet (DRUG), Meal (DIETARY_SUPPLEMENT), Sestamibi (RADIATION), External Heating (OTHER).

Who is sponsoring clinical trial NCT01944215?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01944215's enrollment target sits among peer trials

154 356th of 2000 higher than 1,643 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04300998 · 154 participants

    Study of CAR-T Therapy in Older Patients

  • NCT04597372 · 154 participants · Phase 2

    Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery

  • NCT05294042 · 154 participants · NA

    Patient Navigators for Children's Community Mental Health Services in High Poverty Urban Communities

  • NCT05512390 · 154 participants · Phase 1

    A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01944215, the US trial registry maintained by the National Library of Medicine. NCT01944215 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.